US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

317.20

+12.294.03%

Pre-market: 317.600.4000+0.13%06:30 EDT

Volume:468.50K

Turnover:149.84M

Market Cap:673.89M

PE:- -

High:329.20

Open:311.70

Low:306.27

Close:304.91

52wk High:341.93

52wk Low:66.60

Shares:2.12M

Float Shares:2.12M

Volume Ratio:0.98

T/O Rate:22.05%

Dividend:1.02

Dividend Rate:0.32%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)

Analysts Conflicted on These Healthcare Names: Fate Therapeutics (FATE) and Mediwound (MDWD)

Health Care Roundup: Market Talk

Insulet (PODD) Receives a Hold from Citi

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)

Citi Remains a Buy on Vor Biopharma (VOR)

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)

Press Release: Radnostix, Inc. Reports Fy2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition

Alto Neuroscience, Inc. (ANRO) Receives a Buy from Jefferies

Aveanna Healthcare up over 17%, on Track for Highest Close Since July 2021

Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)

Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), Eton Pharmaceuticals (ETON) and Dyadic International (DYAI)

Sector Update: Healthcare Stocks Advance Pre-Bell Thursday

MT Newswires Live

Analysts’ Top Healthcare Picks: OrthoPediatrics (KIDS), Perrigo Company (PRGO)

Modern Healthcare Technology Details Higher Audit Fee in KPMG Reappointment Plan

Analysts’ Top Healthcare Picks: Neurocrine (NBIX), Aquestive Therapeutics (AQST)

iWOW Shareholders Back S$15 Million Share Placement to Fund Healthcare Nutrition Expansion

Aveanna Healthcare Raises 2026 Outlook After Strong Quarter

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":317.2,"timestamp":1787342400000,"preClose":304.91,"halted":0,"volume":468504,"hourTrading":{"tag":"盘前","latestPrice":317.6,"preClose":317.2,"latestTime":"06:30 EDT","volume":395,"amount":125818.35065,"timestamp":1787567453025,"change":0.4,"changeRate":0.001261,"amplitude":0.013225},"delay":0,"changeRate":0.04030697582893301,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Pre-Mkt","change":12.29,"latestTime":"08-24 06:37:57 EDT","open":311.7,"high":329.2026,"low":306.27,"amount":149839169.98896,"amplitude":0.075211,"askPrice":321.11,"askSize":41,"bidPrice":316.6,"bidSize":3,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":317.2,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.0032,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":317.6,"preClose":317.2,"latestTime":"06:30 EDT","volume":395,"amount":125818.35065,"timestamp":1787567453025,"change":0.4,"changeRate":0.001261,"amplitude":0.013225},"postHourTrading":{"tag":"盘后","latestPrice":317.87,"preClose":317.2,"latestTime":"19:58 EDT","volume":6645,"amount":2111082.7734,"timestamp":1787356729854,"change":0.67,"changeRate":0.002112,"amplitude":0.006526},"volumeRatio":0.9815516107169615,"impliedVol":0.9442,"impliedVolPercentile":0.672},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9815516107169615,"shares":2124486,"dividePrice":1.015,"high":329.2026,"amplitude":0.075211,"preClose":304.91,"low":306.27,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":317.2,"committee":-0.863636,"eps":0,"divideRate":0.0032,"volume":468504,"delay":0,"ttmEps":0,"open":311.7,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":276.54,"twentyDayClose":245.6,"sixtyDayClose":186},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659691971","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659691971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659691971?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:20","pubTimestamp":1786641612,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LABU","LNSR","XLV","BK4581","BK4082","LU0029874061.USD","BK4585","BK4588","XBI","BK4139","BK4137","HCSG","CADL","LU0128526141.USD","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169563","title":"Analysts Conflicted on These Healthcare Names: Fate Therapeutics (FATE) and Mediwound (MDWD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659169563?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:50","pubTimestamp":1786639807,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fate Therapeutics (FATE) and Mediwound (MDWD). Fat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-fate-therapeutics-fate-and-mediwound-mdwd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-fate-therapeutics-fate-and-mediwound-mdwd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD","BK4581","XBI","BK4137","BK4588","BK4139","LU0029874061.USD","HCSG","BK4585","LABU","FATE","LU0128526141.USD","XLV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659461166","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2659461166","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659461166?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:20","pubTimestamp":1786638000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1158 ET - Drugmakers are delaying or forgoing the launch of new ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4588","XBI","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166442","title":"Insulet (PODD) Receives a Hold from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166442?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:15","pubTimestamp":1786637746,"startTime":"0","endTime":"0","summary":"Citi analyst Joanne Wuensch maintained a Hold rating on Insulet today and set a price target of $150.00. Wuensch covers the Healthcare sector, focu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/insulet-podd-receives-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/insulet-podd-receives-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","LABU","BK4585","XLV","BK4581","LU2065171402.SGD","XBI","LU1084165304.USD","LU2065170008.USD","LU2324357040.USD","LU1261432733.SGD","LU2065169927.USD","BK4566","BK4082","LU1119994496.HKD","LU2065171311.SGD","LU0728928796.USD","PODD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166348","title":"Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166348?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:00","pubTimestamp":1786636814,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE) and Biogen (BIIB). Apog...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00B19Z9P08.USD","LU0320765992.SGD","XLV","IE00B894F039.SGD","LU0109394709.USD","LU0029874061.USD","LU0234570918.USD","BK4532","BK4139","BMED","IE00B19Z9Z06.USD","PBE","LU0128526141.USD","APGE","XBI","LU0053671581.USD","HCSG","BIIB","SBIO","LABU","BK4581","BK4588","BK4533","LU0889565916.HKD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659816653","title":"Citi Remains a Buy on Vor Biopharma (VOR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659816653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659816653?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:55","pubTimestamp":1786636543,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Vor Biopharma today and set a price target of $50.00. Meacham covers the Healthcare sector, f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-vor-biopharma-vor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-vor-biopharma-vor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4588","LABU","BK4585","XBI","VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659663051","title":"Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659663051","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659663051?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:50","pubTimestamp":1786636209,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Liquidia Technologies (LQDA), AbbVie (ABBV) and Esta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-liquidia-technologies-lqda-abbvie-abbv-and-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-liquidia-technologies-lqda-abbvie-abbv-and-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","LU2237443978.SGD","SG9999015978.USD","LU0949170772.SGD","IE00B4R5TH58.HKD","XBI","IE000F7OJYX1.SGD","LU0795875169.SGD","LU1989772840.SGD","LU0198837287.USD","IE0002141913.USD","PPH","RXL","IE0009355771.USD","IE00BN8TJ469.HKD","PJP","IE0004445239.USD","LU0738911758.USD","LU2125909247.SGD","BK4559","LU2089283258.USD","BK4585","ESTA","LQDA","LU0256863811.USD","LU0965508806.USD","LU1934455194.USD","IE00BLSP4239.USD","LU0058720904.USD","IYH","LU0965509010.AUD","GLAM","VHT","XLV","IXJ","LU0965509283.SGD","LU0124676726.USD","FTXH","LU0942090050.USD","FHLC","AGNG","IE00BVYPNW00.USD","TRUH","SG9999011175.SGD","LU0545039389.USD","LU1267930573.SGD","JDOC","ABBV","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659663411","title":"Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659663411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659663411?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:46","pubTimestamp":1786635988,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Acumen Pharmaceuticals today and set a price target of $4.00. Meacham covers the Healthcare s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-acumen-pharmaceuticals-abos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-acumen-pharmaceuticals-abos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4581","XLV","BK4139","BK4588","ABOS","XBI","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165757","title":"Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165757?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:40","pubTimestamp":1786635611,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-spyre-therapeutics-syre-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-spyre-therapeutics-syre-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX","LFSC","LU2065731478.USD","LABU","CMPS","BK4581","BK4082","HCSG","BK4585","BK4139","BK4137","LU2324357040.USD","PSIL","LU0029874061.USD","BK4588","XLV","XBI","SYRE","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659416370","title":"Press Release: Radnostix, Inc. Reports Fy2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2659416370","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659416370?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:02","pubTimestamp":1786633320,"startTime":"0","endTime":"0","summary":"IDAHO FALLS, Idaho, Aug. 13, 2026 /PRNewswire/ -- Radnostix, Inc.   , a manufacturer of radioisotope-focused technologies for medical, industrial, and research applications, today announced its financial results for the second quarter and six months ended June 30, 2026 and the filing of its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission.Second Quarter and First Half 2026 Financial and Operational Summary-- Total revenue for the three months ended June 30, 2026 was $2.67 million,a 27% decrease from $3.66 million in the prior-year period. Revenue for. the six months ended June 30, 2026 was $5.05 million, also down 27% from. $6.89 million in the first half of 2025. The declines were driven. Theranostics Products initiated in the first quarter and Cobalt Products. 2026, expanding the Medical Devices segment portfolio.Shahe Bagerdjian, President and Chief Executive Officer, commented: \"The second quarter continued to reflect the temporary but significant impa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4121","BK4585","INIS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165831","title":"Alto Neuroscience, Inc. (ANRO) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165831","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165831?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:45","pubTimestamp":1786632344,"startTime":"0","endTime":"0","summary":"Jefferies analyst Andrew Tsai maintained a Buy rating on Alto Neuroscience, Inc. today and set a price target of $40.00. Tsai covers the Healthcare...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alto-neuroscience-inc-anro-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alto-neuroscience-inc-anro-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4585","XLV","BK4588","ANRO","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659638163","title":"Aveanna Healthcare up over 17%, on Track for Highest Close Since July 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2659638163","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659638163?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:41","pubTimestamp":1786632060,"startTime":"0","endTime":"0","summary":"Aveanna Healthcare Holdings Inc  is currently at $10.64, up $1.59 or 17.51%--Would be highest close since July 23, 2021, when it closed at $10.84--On pace for largest percent increase since Aug. 7, 2025, when it rose 49.36%--Currently up two consecutive days; up 18.83% over this period--Best two day stretch since the two days ending Aug. 8, 2025, when it rose 57.84%--Up 13.26% month-to-date--Up 30.17% year-to-date--Down 17.49% from its all-time closing high of $12.89 on June 14, 2021--Up 47.71% from 52 weeks ago , when it closed at $7.20--Would be a new 52-week closing high--Up 70.98% from its 52-week closing low of $6.22 on April 10, 2026--Traded as high as $10.80; highest intraday level since July 26, 2021, when it hit $10.99--Up 19.34% at today's intraday high; largest intraday percent increase since Aug. 7, 2025, when it rose as much as 59.38%All data as of 10:38:37 AM ETSource: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BK4588","XLV","BK4196","AVAH","LABU","LU0128526141.USD","XBI","BK4581","BK4137","HCSG","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659168244","title":"Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659168244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659168244?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:10","pubTimestamp":1786630208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Connect Biopharma Holdings (CNTB) and Biomea Fusion ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","CNTB","BK4539","BK4581","XBI","LABU","BK4585","LU0029874061.USD","BK4139","BK4588","XLV","BMEA","HCSG","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659150152","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), Eton Pharmaceuticals (ETON) and Dyadic International (DYAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659150152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659150152?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:40","pubTimestamp":1786628423,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ProKidney (PROK), Eton Pharmaceuticals (ETON) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-prokidney-prok-eton-pharmaceuticals-eton-and-dyadic-international-dyai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-prokidney-prok-eton-pharmaceuticals-eton-and-dyadic-international-dyai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ETON","BK4588","LU0029874061.USD","XLV","PROK","BK4139","LABU","LU0128526141.USD","XBI","BK4581","BK4137","BK4007","HCSG","DYAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659574871","title":"Sector Update: Healthcare Stocks Advance Pre-Bell Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2659574871","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659574871?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:13","pubTimestamp":1786626787,"startTime":"0","endTime":"0","summary":"Healthcare stocks were advancing pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF  up 0.3% and the iShares Biotechnology ETF  0.6% higher.MeiraGTx  shares were up more than 7% after the company reported that it swung to a Q2 net income as revenue surged during the period.Cullinan Therapeutics , Taiho Oncology and Taiho Pharmaceutical said a phase 3 clinical trial evaluating the combination of their jointly developed drug zipalertinib and chemotherapy as a first-line treatment for adults with previously untreated, locally advanced or metastatic non-small cell lung cancer met its primary endpoint of progression-free survival. Shares of Cullinan Therapeutics were up more than 7% premarket.Ascendis Pharma  stock was up more than 1% after the company posted higher Q2 non-IFRS earnings and revenue.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","HCSG","BK4585","BK4139","LABU","LU0128526141.USD","MEDI","XLV","BK4588","LU0320765992.SGD","LU0889565916.HKD","CGEM","LU0109394709.USD","BK4581","IBB","XBI","MGTX","LU0029874061.USD","ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659152671","title":"Analysts’ Top Healthcare Picks: OrthoPediatrics (KIDS), Perrigo Company (PRGO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659152671","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659152671?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:40","pubTimestamp":1786624813,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on OrthoPediatrics (KIDS), Perrigo Company (PRGO) and M...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-orthopediatrics-kids-perrigo-company-prgo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-orthopediatrics-kids-perrigo-company-prgo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","LU0029874061.USD","BK4198","LU0128526141.USD","XLV","BK4585","XBI","IE00BFMHRM44.USD","BK4007","KIDS","PRGO","BK4581","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659678152","title":"Modern Healthcare Technology Details Higher Audit Fee in KPMG Reappointment Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2659678152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659678152?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:37","pubTimestamp":1786624671,"startTime":"0","endTime":"0","summary":"An update from Modern Healthcare Technology Holdings Limited ( ($HK:0919) ) is now available. Modern Healthcare Technology Holdings Limited has iss...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/modern-healthcare-technology-details-higher-audit-fee-in-kpmg-reappointment-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/modern-healthcare-technology-details-higher-audit-fee-in-kpmg-reappointment-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0029874061.USD","XLV","HCSG","BK4137","LU0128526141.USD","BK4585","LABU","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659154461","title":"Analysts’ Top Healthcare Picks: Neurocrine (NBIX), Aquestive Therapeutics (AQST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659154461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659154461?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:20","pubTimestamp":1786623610,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neurocrine (NBIX), Aquestive Therapeutics (AQST) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-neurocrine-nbix-aquestive-therapeutics-aqst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-neurocrine-nbix-aquestive-therapeutics-aqst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2065171311.SGD","BK4137","LU0154245756.USD","LU0109394709.USD","AQST","LABU","NBIX","LU0320765992.SGD","LU0029874061.USD","HCSG","LU2065169927.USD","BK4007","BK4588","LU0154245673.USD","LU0889565916.HKD","XBI","BK4139","LU2324357040.USD","XLV","LU0823416689.USD","BK4581","LU2065170008.USD","LU2065171402.SGD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151337","title":"iWOW Shareholders Back S$15 Million Share Placement to Fund Healthcare Nutrition Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151337","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151337?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:39","pubTimestamp":1786621151,"startTime":"0","endTime":"0","summary":"The latest update is out from iWOW Technology Limited ( ($SG:NXR) ). iWOW Technology Limited convened an extraordinary general meeting on 16 July 2...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/iwow-shareholders-back-s15-million-share-placement-to-fund-healthcare-nutrition-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/iwow-shareholders-back-s15-million-share-placement-to-fund-healthcare-nutrition-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0029874061.USD","HCSG","XBI","BK4209","BK4137","BK4581","XLV","LABU","BK4588","SG","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151333","title":"Aveanna Healthcare Raises 2026 Outlook After Strong Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151333","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151333?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:36","pubTimestamp":1786620999,"startTime":"0","endTime":"0","summary":"An announcement from Aveanna Healthcare Holdings ( ($AVAH) ) is now available. Aveanna Healthcare Holdings reported strong financial results for th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-raises-2026-outlook-after-strong-quarter?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-raises-2026-outlook-after-strong-quarter?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4539","BK4585","HCSG","BK4588","LU0029874061.USD","XBI","AVAH","LU0128526141.USD","BK4581","BK4137","BK4196","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":13,"totalSize":389,"code":"91000000","status":"200"}]}}